Pediatrix Medical Group, Inc. (NYSE:MD) Receives Consensus Recommendation of "Hold" from Analysts

Shares of Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) have received an average recommendation of "Hold" from the five ratings firms that are presently covering the stock, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $9.30.

A number of equities research analysts have weighed in on the company. StockNews.com raised Pediatrix Medical Group from a "sell" rating to a "hold" rating in a report on Wednesday, August 7th. UBS Group raised their price objective on Pediatrix Medical Group from $9.00 to $10.50 and gave the company a "neutral" rating in a research note on Friday, August 9th. Truist Financial lifted their target price on Pediatrix Medical Group from $8.00 to $10.00 and gave the company a "hold" rating in a research report on Thursday, August 15th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Pediatrix Medical Group from a "sell" rating to a "hold" rating and set a $8.00 target price for the company in a report on Friday, June 7th.

Pediatrix Medical Group Price Performance

MD stock traded down $0.31 during midday trading on Friday, reaching $10.56. The company had a trading volume of 2,139,314 shares, compared to its average volume of 508,393. Pediatrix Medical Group has a 1-year low of $6.62 and a 1-year high of $13.01. The stock has a 50 day moving average price of $9.71 and a 200-day moving average price of $8.82. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.38 and a quick ratio of 1.38. The company has a market capitalization of $888.59 million, a price-to-earnings ratio of -12.42, a price-to-earnings-growth ratio of 1.68 and a beta of 1.56.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Tuesday, August 6th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.31 by $0.03. The company had revenue of $504.30 million during the quarter, compared to analysts' expectations of $505.49 million. Pediatrix Medical Group had a negative net margin of 12.58% and a positive return on equity of 10.59%. The business's revenue for the quarter was up .7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.37 EPS. Equities research analysts expect that Pediatrix Medical Group will post 1.18 earnings per share for the current year.

Insiders Place Their Bets

In related news, CFO C Marc Richards sold 17,438 shares of the firm's stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $10.08, for a total value of $175,775.04. Following the completion of the transaction, the chief financial officer now owns 175,347 shares in the company, valued at approximately $1,767,497.76. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other Pediatrix Medical Group news, CEO James D. Swift sold 11,100 shares of Pediatrix Medical Group stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $10.79, for a total transaction of $119,769.00. Following the transaction, the chief executive officer now directly owns 170,001 shares of the company's stock, valued at approximately $1,834,310.79. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO C Marc Richards sold 17,438 shares of the stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $10.08, for a total value of $175,775.04. Following the completion of the sale, the chief financial officer now directly owns 175,347 shares of the company's stock, valued at approximately $1,767,497.76. The disclosure for this sale can be found here. Insiders sold a total of 68,100 shares of company stock valued at $701,889 in the last 90 days. Corporate insiders own 2.00% of the company's stock.

Institutional Trading of Pediatrix Medical Group

Several institutional investors have recently added to or reduced their stakes in the stock. nVerses Capital LLC acquired a new stake in Pediatrix Medical Group during the 2nd quarter worth about $31,000. Innealta Capital LLC bought a new stake in shares of Pediatrix Medical Group during the 2nd quarter valued at about $33,000. Nisa Investment Advisors LLC grew its stake in Pediatrix Medical Group by 47.2% during the second quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company's stock worth $36,000 after purchasing an additional 1,524 shares during the period. Canada Pension Plan Investment Board bought a new stake in Pediatrix Medical Group in the second quarter worth approximately $72,000. Finally, Vanguard Personalized Indexing Management LLC acquired a new position in Pediatrix Medical Group in the second quarter valued at approximately $81,000. 97.71% of the stock is currently owned by institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.